Article Details
Retrieved on: 2023-01-12 06:16:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Basel, 12 January 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has approved Xofluza (baloxavir marboxil) ...
Article found on: www.wallstreet-online.de
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here